Heron Therapeutics Inc.宣布即将召开的特别股东大会的日期
Heron Therapeutics Inc. has announced a Special Meeting of Stockholders scheduled for October 13, 2025. Stockholders will vote on proposals including the approval of share issuance related to the conversion of convertible senior unsecured promissory notes due 2031 and Series A Convertible Preferred Stock. Other business matters may also be addressed during the meeting.
Heron Therapeutics Inc. has scheduled a Special Meeting of Stockholders to take place on October 13, 2025. During the meeting, stockholders will vote on several proposals. These include the approval of the issuance of shares of the company’s common stock in connection with the conversion of convertible senior unsecured promissory notes due 2031, as well as the issuance of shares in connection with the conversion of the company’s Series A Convertible Preferred Stock. Additionally, other business matters that may properly come before the Special Meeting will also be addressed. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heron Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-209064), on September 19, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
